Yair Lotan - Concepedia

Author

Yair Lotan

The University of Texas Southwestern Medical Center ORCID

Also Known As

Daniel W. Lin, Lorie Grant, Lotan, Yair, Mark Stovsky, Meng, Shaowu, Michael Nasterlack, Ryan Hutchinson, Y Lotan, Y. LOTAN, Y. Lotan

1.5K

Publications

59.4K

Citations

113

H-Index

186

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Université de Montréal Cornell University The University of Texas MD Anderson Cancer Center Medical University of Vienna

About

Yair Lotan is an author at The University of Texas Southwestern Medical Center specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	63	212	14.3K
2	Health Sciences	9	9	459
3	Engineering	7	7	459
4	Business	1	1	43
5	Natural Sciences	1	1	10

Yair Lotan

491

Publications

37K

Citations

H-Index

Page 1

	Year	Citations
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration Vitaly Margulis, Shahrokh F. Shariat, Surena F. Matin, Cancer	2009	1.1K
BAP1 loss defines a new class of renal cell carcinoma Samuel Peña‐Llopis, Silvia Vega-Rubín-de-Celis, Arnold Liao, Nature Genetics	2012	973
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline Sam S. Chang, Bernard H. Bochner, Roger Chou, The Journal of Urology	2017	920
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma Lauren Fishbein, Ignaty Leshchiner, Vonn Walter, Cancer Cell MedicineComprehensive Molecular CharacterizationPathologyAdrenal DiseaseMolecular Diagnostics	2017	750
Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium Shahrokh F. Shariat, Pierre I. Karakiewicz, Ganesh S. Palapattu, The Journal of Urology	2006	696
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, The Lancet Oncology UrologyOncologyGenitourinary CancerMedicineRepeat-dose Clinical Trial	2020	412
Climate-related increase in the prevalence of urolithiasis in the United States Tom Brikowski, Yair Lotan, Margaret S. Pearle Proceedings of the National Academy of Sciences Stone RiskUrologyUrological ResearchThreshold TemperatureEnvironmental Health	2008	383
Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in 2030 Jodi Antonelli, Naim M. Maalouf, Margaret S. Pearle, European Urology ObesityUrological ResearchUrologyNutritional EpidemiologyHealth Policy	2014	377
Discrepancy between Clinical and Pathologic Stage: Impact on Prognosis after Radical Cystectomy Shahrokh F. Shariat, Ganesh S. Palapattu, Pierre I. Karakiewicz, European Urology Radical CystectomyUrologySurgical OncologyGynecological SurgeryMedicine	2006	361
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes Steffen Durinck, Eric Stawiski, Andrea Pavía-Jiménez, Nature Genetics UrologyDiverse Genomic AlterationsGenitourinary CancerTumor HeterogeneityMedicine	2014	353

Page 1